Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients

AIDS

Volumn 16, Issue 10, 2002, Pages 1421-1423

  Goetz, Matthew Bidwell ^a   Feikin, Daniel R ^b   Lennox, Jeffrey L ^c   O'Brien, William A ^d   Elie, Cheryl M ^c   Butler, Jay C ^c   Breiman, Robert F ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; PLACEBO; PNEUMOCOCCUS VACCINE; VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD; VIRUS REPLICATION; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; FOLLOW UP; LETTER; STREPTOCOCCUS INFECTION; VACCINATION; VIROLOGY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMAN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SUPPORT, U.S. GOV'T, P.H.S.; VACCINATION; VACCINES, CONJUGATE; VIRAL LOAD; HUMANS;

EID: 0037024763     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207050-00015     Document Type: Article

References (19)

1. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine
2. Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha
3. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination
4. Activation of virus replication after vaccination of HIV-1-infected individuals
5. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy
6. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children
7. Effects of influenza vaccination in HIV-infected adults: A double-blind, placebo-controlled trial
8. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals
9. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults
10. Lack of effect of immunization on viral load and circulating HIV-1 quasispecies and phenotype
11. Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial
12. Pneumococcal and influenza immunization and human immunodeficiency virus load in children
13. Assessments of plasma HIV RNA and CD4 cell counts after combined Pneumovax and tetanus toxoid vaccination: No detectable increase in HIV replication 6 weeks after immunization
14. Immune activation and virologic response to immunization in recent HIV type 1 seroconverters
15. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients
16. The effect of influenza vaccination on human immunodeficiency virus type 1 load: A randomized, double-blind, placebo-controlled study
17. Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus
18. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: Impact on plasma levels of HIV type 1 RNA and determinants of antibody response
19. The kinetics of plasma HIV RNA following influenza vaccination